[Nanomedicine: chance or risk for the patients?].
Kathmann
Wiebke
W
D003550:Cystic Fibrosis / Q000628:therapy; D016503:Drug Delivery Systems / Q000379:methods; D015316:Genetic Therapy / Q000379:methods; D006801:Humans; D050997:Nanomedicine / Q000379:methods / Q000592:standards* / Q000639:trends; D053758:Nanoparticles / Q000009:adverse effects / Q000627:therapeutic use*; D009369:Neoplasms / Q000628:therapy; D012307:Risk Factors